Liver cancer is one of the most serious cancers worldwide, and it is a growing concern in Bangladesh, where hepatitis B and C infections and fatty liver disease are common. The most frequent type of primary liver cancer is hepatocellular carcinoma (HCC), which arises from the main cells of the liver.


The most important message about HCC is this: when it is detected early, it can often be cured. Unfortunately, many patients are diagnosed late because early HCC usually causes no symptoms. This article explains who is at risk, how regular screening can catch the cancer early, how it is diagnosed and staged, and how surgical resection and other treatments can offer a chance of cure.


What Is Hepatocellular Carcinoma?

HCC is a cancer that starts in the hepatocytes, the cells that carry out most of the liver's work. Unlike cancers that spread to the liver from other organs (called secondary or metastatic liver cancer), HCC begins in the liver itself. In most patients, it develops in a liver that is already damaged by long-term disease, especially cirrhosis.


Who Is at Risk?

Most cases of HCC occur in people with known risk factors. This is why targeted screening works so well. The main risk factors are:


Chronic hepatitis B infection: the leading cause of HCC in Bangladesh and much of Asia. It can cause HCC even without cirrhosis.

Chronic hepatitis C infection

Cirrhosis from any cause

Fatty liver disease (MASLD/NAFLD), linked with obesity, diabetes, and high cholesterol. This is a rapidly increasing cause.

Alcohol use

Aflatoxin: a toxin produced by moulds on poorly stored grains and nuts

Diabetes and obesity

Smoking

A family history of HCC, particularly in families affected by hepatitis B

Rare inherited conditions such as haemochromatosis

Why Early Detection Matters

Early HCC is usually small, confined to the liver, and causes no symptoms. At this stage, curative treatments such as surgical resection, ablation, or transplantation are possible, and long-term survival is realistic. Once symptoms appear, the tumour is often large or has spread, and treatment options become limited.


Studies have consistently shown that patients whose HCC is found through regular screening are more likely to receive curative treatment and live longer than those diagnosed after symptoms appear.


Screening: Who Should Be Checked and How?

International guidelines recommend surveillance every 6 months for high-risk people, including:


All patients with cirrhosis, whatever the cause

People with chronic hepatitis B, especially men over 40, women over 50, those with a family history of HCC, and people of African origin

Selected patients with advanced liver fibrosis from hepatitis C or fatty liver disease

Screening is simple and affordable:


Ultrasound of the liver every 6 months

Serum alpha-fetoprotein (AFP) blood test, which is often combined with ultrasound

If anything suspicious is found, further tests are arranged promptly.


Symptoms of Liver Cancer

When symptoms do occur, they may include:


Pain or discomfort in the upper right abdomen

A lump or feeling of fullness under the right ribs

Unexplained weight loss and loss of appetite

Tiredness and weakness

Swelling of the abdomen (ascites)

Yellowing of the eyes and skin

Sudden worsening of known cirrhosis

Sudden severe pain and collapse, which can happen if the tumour bleeds

Anyone with liver disease who notices these symptoms should be assessed urgently.


How Is HCC Diagnosed?

A special feature of HCC is that it can often be diagnosed by its typical appearance on scans, without the need for a biopsy, in patients with cirrhosis.


Triple-phase contrast CT scan or contrast MRI of the liver: HCC shows a characteristic pattern, lighting up in the arterial phase and "washing out" in later phases.

AFP: often raised, but normal in a significant number of patients

Liver biopsy: needed when the scan appearance is not typical

Chest CT and sometimes bone scan or PET-CT: to check for spread

Hepatitis B and C tests, and an assessment of underlying liver disease

Assessing Liver Function: A Critical Step

In HCC, treatment depends not only on the tumour but also on how well the rest of the liver works. A large operation on a weak liver can lead to liver failure. Your team will assess:


Child-Pugh score, based on bilirubin, albumin, clotting, ascites, and confusion

Portal hypertension: raised pressure in the liver's blood supply, assessed through scans, platelet count, and endoscopy for varices

Future liver remnant: the volume of healthy liver that would remain after surgery, measured with CT volumetry

Performance status: your general fitness and daily activity level

These factors are combined in staging systems such as the Barcelona Clinic Liver Cancer (BCLC) system to guide the best treatment.


Curative Treatment Options

1. Surgical Resection (Hepatectomy)

Liver resection means surgically removing the part of the liver containing the tumour. It is one of the most effective curative treatments for HCC. It is best suited for patients with:


A single tumour, or a limited number of tumours, confined to one part of the liver

Good liver function (usually Child-Pugh A)

No significant portal hypertension

An adequate volume of remaining healthy liver

No spread outside the liver and no major blood vessel invasion

The liver has a remarkable ability to regenerate. In a healthy liver, up to about 70% can be removed safely, and the remaining liver grows back within weeks. In a cirrhotic liver, less can be removed, which is why careful assessment is essential.


Depending on the tumour, the operation may be a segmentectomy (removal of one segment), a sectionectomy, or a right or left hepatectomy (removal of one half of the liver). In selected patients, laparoscopic liver resection is possible and offers faster recovery.


When the remaining liver is expected to be too small, a procedure called portal vein embolisation may be done weeks beforehand to make the healthy part grow larger before surgery.


2. Liver Transplantation

For patients with early HCC and poor liver function from cirrhosis, transplantation treats both the cancer and the underlying liver disease. Eligibility is usually based on tumour size and number, such as the Milan criteria: one tumour up to 5 cm, or up to three tumours each up to 3 cm, without vascular invasion or spread.


3. Ablation

Small tumours, generally under 3 cm, can be destroyed with heat using radiofrequency ablation (RFA) or microwave ablation (MWA), through a needle placed under scan guidance. It is an excellent option for small tumours in patients who are not suitable for surgery.


Other Treatment Options

For more advanced disease, treatment aims to control the cancer, prolong life, and maintain quality of life:


TACE (transarterial chemoembolisation): chemotherapy delivered directly into the tumour's artery, then the artery is blocked

TARE/SIRT: radioactive beads delivered into the tumour's blood supply

Stereotactic radiotherapy for selected tumours

Systemic therapy: modern immunotherapy combinations and targeted medicines for advanced disease

Sometimes these treatments shrink a tumour enough to make surgery possible later.


Recovery After Liver Resection

A hospital stay of about 5 to 10 days, depending on the extent of surgery

Close monitoring of liver function, bleeding, and bile leak in the first days

Early walking and breathing exercises

Gradual return to normal diet, with good protein intake

Full recovery over 6 to 8 weeks

Follow-Up After Treatment

HCC can recur, either at the original site or elsewhere in the liver, because the underlying liver disease remains. Regular follow-up is essential:


CT or MRI scans and AFP every 3 months for the first two years, then less often

Continued treatment of hepatitis B or C with antiviral medicines

Management of fatty liver, diabetes, and weight

Complete avoidance of alcohol

When recurrence is detected early, it can often be treated again with resection, ablation, or other therapies.


Prevention: Reducing Your Risk

Hepatitis B vaccination, which is safe and highly effective. Make sure all family members are vaccinated.

Testing for hepatitis B and C, especially if you have had blood transfusions, surgery, or a family history

Antiviral treatment for chronic hepatitis B and C, which greatly reduces cancer risk

Maintaining a healthy weight and controlling diabetes

Avoiding alcohol and tobacco

Storing grains and nuts in dry conditions to avoid mould and aflatoxin

Regular screening if you are in a high-risk group

The Role of the Family

Treatment for liver cancer is an emotionally and financially demanding journey for both patients and families. Family members play a major role by bringing the patient to regular follow-up visits, making sure medicines are taken properly, ensuring good nutrition, and offering emotional support. Because hepatitis B can spread within families, the patient's spouse, children, and siblings should also be tested for hepatitis B and vaccinated if needed. At every stage, seek coordinated advice from the surgeon, oncologist, and hepatologist, and never hesitate to ask questions.


Common Myths

"Liver cancer cannot be cured." Early HCC can often be cured with surgery, ablation, or transplantation.

"If my liver tests are normal, I cannot have liver cancer." Liver function tests can be normal in early HCC; that is why screening uses ultrasound and AFP.

"Hepatitis B carriers do not need follow-up if they feel well." Carriers can develop HCC without symptoms and need regular monitoring.

Conclusion

Hepatocellular carcinoma is a serious disease, but it is not a hopeless one. Most cases arise in people with known risk factors such as hepatitis B, hepatitis C, cirrhosis, and fatty liver, so regular six-monthly screening can catch the cancer early, when curative surgery and other treatments are possible. Decisions about resection require careful assessment of both the tumour and the liver, and should be made by an experienced hepatobiliary team.


If you have hepatitis B or C, cirrhosis, or a liver lesion found on a scan, consult a hepatobiliary surgeon for a clear assessment and plan.


This article is for general information and does not replace a personal medical consultation. Please discuss your individual treatment plan with your doctor.